Establishing Good Practices for Exposure–Response Analysis of Clinical Endpoints in Drug Development

E-ISSN： 2163-8306|4|10|565-575

ISSN： 2163-8306

Source： Cpt: Pharmacometrics & Systems Pharmacology, Vol.4, Iss.10, 2015-10, pp. : 565-575

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of a Copper Database for Exposure-Response Analysis

By Krewski Daniel Chambers Andrea Stern Bonnie Ransom Aggett Peter Plunkett Laura Rudenko Larisa

Journal of Toxicology and Environmental Health, Vol. 73, Iss. 2-3, 2010-01 ,pp. : 208-216

Taylor & Francis Ltd

Access to resources Recommend Favorite

CHLOROFORM: EXPOSURE ESTIMATION, HAZARD CHARACTERIZATION, AND EXPOSURE-RESPONSE ANALYSIS

By Meek M. E. Beauchamp R. Long G. Moir D. Turner L. Walker M.

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 5, Iss. 3, 2002-07 ,pp. : 283-334

Taylor & Francis Ltd

Access to resources Recommend Favorite

1,3-Butadiene: Exposure Estimation, Hazard Characterization, and Exposure-Response Analysis

By Hughes K. Meek M. E. Walker M. Beauchamp R.

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 6, Iss. 1, 2003-01 ,pp. : 55-83

Taylor & Francis Ltd

Access to resources Recommend Favorite

Inhaled Formaldehyde: Exposure Estimation, Hazard Characterization, and Exposure-Response Analysis

By Liteplo R. G. Meek M. E.

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 6, Iss. 1, 2003-01 ,pp. : 85-114

Taylor & Francis Ltd

Access to resources Recommend Favorite

Good clinical endpoints with denosumab in osteoporosis and cancer

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2939-2943

Informa Healthcare

Access to resources Recommend Favorite